DecisionMap Wealth Management LLC Invests $593,000 in Zoetis Inc. $ZTS

DecisionMap Wealth Management LLC acquired a new position in Zoetis Inc. (NYSE:ZTS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,805 shares of the company’s stock, valued at approximately $593,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC grew its position in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after buying an additional 2,978 shares during the last quarter. Intact Investment Management Inc. lifted its stake in shares of Zoetis by 475.0% in the first quarter. Intact Investment Management Inc. now owns 2,300 shares of the company’s stock worth $379,000 after acquiring an additional 1,900 shares during the period. Flagship Harbor Advisors LLC boosted its holdings in Zoetis by 31.2% in the first quarter. Flagship Harbor Advisors LLC now owns 7,394 shares of the company’s stock valued at $1,217,000 after acquiring an additional 1,760 shares during the last quarter. TrueMark Investments LLC acquired a new stake in Zoetis during the 1st quarter valued at approximately $228,000. Finally, Oppenheimer Asset Management Inc. raised its holdings in Zoetis by 18.6% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 275,734 shares of the company’s stock worth $45,400,000 after purchasing an additional 43,325 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ZTS. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and reduced their price objective for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. UBS Group dropped their price objective on Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a research note on Monday. Finally, Piper Sandler raised their target price on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Four analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Zoetis has an average rating of “Hold” and a consensus target price of $195.00.

Zoetis Price Performance

ZTS stock opened at $145.11 on Tuesday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The company’s 50-day moving average is $148.65 and its 200-day moving average is $153.60. The stock has a market capitalization of $64.31 billion, a PE ratio of 24.98, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. Zoetis Inc. has a 1 year low of $139.34 and a 1 year high of $193.00.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm’s revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is currently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.